|

Antidepressants and Violence

David Healy research with sources. It’s time to admit there is a link to violence and antidepressants. To say otherwise verges on ignorance.

Published in 2006, warnings about
adverse behavioural effects of
antidepressants
in susceptible
individuals have raised the profile of
these issues with clinicians, patients,
and the public.

  1. Healy D (2004) Let them eat Prozac. New York:
    New York University Press. pp. 124–148.
  2. Pfizer Canada (2004 May 26) Stronger warning
    for SSRIs and other newer antidepressants
    regarding the potential for behavioural and
    emotional changes, including risk of self-harm.
    Available: http:⁄⁄www.hc-sc.gc.ca/dhp-mps/
    medeff/advisories-avis/prof/2004/
    zoloft_2_hpc-cps_e.html. Accessed 21 July 2006.
  3. Pfi zer (2005 February) Zoloft prescribing
    information. Available: http:⁄⁄www.fda.gov/
    cder/foi/label/2005/019839s053S054lbl.pdf.
    Accessed 21 July 2006.
  4. Medicines and Healthcare Products
    Regulatory Agency (2004) Report of the
    CSM expert working group on the safety
    of selective serotonin reuptake inhibitors.
    Available: http:⁄⁄www.mhra.gov.uk/home/
    idcplg?IdcService=GET_FILE&dDocName=
    CON019472&RevisionSelectionMethod=
    LatestReleased. Accessed 21 July 2006.
  5. GlaxoSmithKline (2006) Paroxetine adult
    suicidality analysis: Major depressive disorder
    and non-major depressive disorder—Appendix
  6. Available: http:⁄⁄www.gsk.com/media/
    par_current_analysis.htm. Accessed 21 July
    1. Inman W, Kubota K, Pearce G, Wilton L
      (1993) P.E.M report number 6. Paroxetine.
      Pharmacoepidemiol Drug Saf 2: 393–422.
  7. Edwards JG, Inman WH, Wilton L, Pearce GL,
    Kubota K (1997) Drug safety monitoring of
    12692 patients treated with fl uoxetine. Hum
    Psychopharmacol 12: 127–137.
  8. Healy D (2000) Emergence of antidepressant
    induced suicidality. Prim Care Psychiatry 6:
    23–28.
  9. Wagner KD, Ambrosini P, Rynn M, Wohlberg
    C, Yang R, et al. (2003) Effi cacy of sertraline in
    the treatment of children and adolescents with
    major depressive disorder: Two randomized
    controlled trials. JAMA 290: 1033–1041.
  10. March JS, Biederman J, Wolkow R, Safferman
    A, Mardekian J, et al. (1998) Sertraline
    in children and adolescents with OCD: A
    multicenter randomized controlled trial. JAMA
    280: 1752–1758.
  11. Kuslak V (2003 August 22) Letter to physicians.
    Wyeth Pharmaceuticals.
  12. Medicines and Healthcare Products
    Regulatory Agency (2006) Adverse drug
    reactions online information tracking: Drug
    analysis print. Available: http:⁄⁄www.mhra.
    gov.uk/home/groups/public/documents/
    sentineldocuments/dap_1130236020641.pdf.
    Accessed 26 July 2006.
  13. Pirmohamed M, Breckenridge AM,
    Kitteringham NR, Park BK (1998) Adverse
    drug reactions. BMJ 316: 1295–1298.
  14. Medawar C, Herxheimer A, Bell A, Jofre
    S (2002) Paroxetine, Panorama and user
    reporting of ADRs: Consumer intelligence
    matters in clinical practice and post-marketing
    drug surveillance. Int J Risk Saf Med 15: 161
    169.
  15. Medawar C, Herxheimer A (2003) A
    comparison of adverse drug reaction reports
    from professionals and users, relating to risk
    of dependence and suicidal behaviour with
    paroxetine. Int J Risk Saf Med 16: 3–17.
  16. Healy D, Aldred G (2005) Antidepressant drug
    use and the risk of suicide. Int Rev Psychiatry
    17: 163–172.
  17. Healy D, Whitaker CJ (2003) Antidepressants
    and suicide: Risk-benefi t conundrums. J
    Psychiatry Neurosci 28: 331–339.
  18. Healy D, Savage M (1998) Reserpine exhumed.
    Brit J Psychiatry 172: 376–378.
  19. Cunningham Owens DG (1999) A guide to
    the extrapyramidal side-effects of antipsychotic
    drugs. Cambridge: Cambridge University Press.
    362 p.
  20. Duncan EJ, Adler LA, Stephanides M, Sanfi lipo
    M, Angrist B (2000) Akathisia and exacerbation
    of psychopathology: A preliminary report. Clin
    Neuropharmacol 23: 169–173.
  21. American Psychiatric Association (2000)
    Diagnostic and statistical manual IV TR.
    Washington (D. C.): American Psychiatric
    Association.
  22. Lane RM (1998) SSRI-induced extrapyramidal
    side effects and akathisia: Implications for
    treatment. J Psychopharmacol 12: 192–214.
  23. Siris SG (1985) Three cases of akathisia and
    “acting out”. J Clin Psychiatry 46: 395–397.
  24. Herrera JN, Sramek JJ, Costa JF, Roy S, Heh
    CW, et al. (1988) High potency neuroleptics
    and violence in schizophrenia. J Nerv Ment Dis
    176: 558–561.
  25. Schulte JR (1985) Homicide and suicide
    associated with akathisia and haloperidol. Am J
    Forensic Psychiatry 6: 3–7.
  26. Hoehn-Saric R, Lipsey JR, McLeod DR
    (1990) Apathy and indifference in patients
    on fl uvoxamine and fl uoxetine. J Clin
    Psychopharmacol 10: 343–345.
  27. Wilkinson D (1990) Loss of anxiety and
    increased aggression in a 15-year-old boy taking
    f
    l uoxetine. J Psychopharmacol 13: 420.
  28. Garland EJ, Baerg EA (2001) Amotivational
    syndrome associated with selective serotonin
    reuptake inhibitors in children and adolescents.
    J Child Adolesc Psychopharmacol 11: 181–186.
  29. Barnhart WJ, Makela EH, Latocha MJ (2004)
    SSRI-induced apathy syndrome: A clinical
    review. J Psychiatr Pract 10: 196–199.
  30. Wilens TE, Biederman J, Kwon A, Chase R,
    Greenberg L, et al. (2003) A systematic chart
    review of the nature of psychiatric adverse
    events in children and adolescents treated with
    selective serotonin reuptake inhibitors. J Child
    Adolesc Psychopharmacol 13: 143–152.
  31. Preda A, MacLean RW, Mazure CM, Bowers
    MB (2001) Antidepressant associated
    mania and psychosis resulting in psychiatric
    admission. J Clin Psychiatry 62: 30–33.
  32. Nakra BR, Szwabo P, Grossberg GT (1989)
    Mania induced by fl uoxetine. Am J Psychiatry
    146: 1515–1516.
  33. Hersh CB, Sokol MS, Pfeffer C (1991)
    Transient psychosis with fl uoxetine. J Am Acad
    Child Adolesc Psychiatry 30: 851–852.
  34. Stoll AL, Mayer PV, Kolbrener M, Goldstein
    E, Suplit B, et al. (1994) Antidepressant
    associated mania: A controlled comparison
    with spontaneous mania. Am J Psychiatry 151:
    1642–1645.
  35. Narayan M, Meckler L, Nelson JC (1995)
    Fluoxetine-induced delusions in psychotic
    depression. J Clin Psychiatry 56: 329.
  36. Alao A, Yolles JC, Armenta WC, Dewan MJ
    (1991) Somnambulism precipitated by selective
    serotonin-reuptake inhibitors. J Pharm Technol
    15: 204–207.
  37. Kawashima T, Yamada S (2003) Paroxetine
    induced somnambulism. J Clin Psychiatry 64:
    483.
  38. Rampling D (1978) Aggression: A paradoxical
    response to tricyclic antidepressants. Am J
    Psychiatry 135: 117–118.
  39. United States District Court of Wyoming
    (2001) Tobin v. SmithKline Beecham
    Pharmaceuticals. Fed Suppl 164: 1278.
  40. New South Wales Supreme Court (2001)
    Regina v. Hawkins. NSWSC 420: paragraph 66.
  41. Supreme Court of Western Australia (2004)
    State of Western Australia and B, Sentence,
    Transcript of Proceedings, Perth, May 26, 2004.
    67 of 2004.
  42. Mendelson WB (1994) Sleepwalking associated
    with zolpidem. J Clin Psychopharmacol 14: 150.
  43. Harazin J, Berigan TR (1999) Zolpidem tartrate
    and somnambulism. Mil Med 164: 669–670.
  44. Baonza MY, Garcia-Borra JMF, Majada
    AC, Gonzalez RS (2003) [Somnambulism
    associated with zolpidem.] [Article in Spanish]
    Aten Primaria 32: 438.
  45. Menkes DB (2000) Hypnosedatives and
    anxiolytics. In: Dukes MNG, Aronson JK,
    editors. Meyler’s side effects of drugs. 14th
    Edition. Amsterdam: Elsevier. pp. 121–138.
  46. Supreme Court of Mississippi (2002) Bennett v.
    Madakasira. So. 2d 821: 794.
  47. 7th Circuit Court of Florida for St. Johns
    County (2006) State of Florida v. Leslie
    Demeniuk. Case Number CF-01-930.
  48. (2005) State of South Carolina v.
    Christopher Frank Pittman. Case Number
    04-GS-12-571.
  49. Springer J (2005 February 16) Jurors find
    teenager guilty of murdering his grandparents.
    Court TV News. Available: http:⁄⁄www.courttv.
    com/trials/pittman/021505_verdict_ctv.html.
    Accessed 1 August 2006.
  50. (2005) State of South Carolina v. Christopher
    Frank Pittman. Case Number 04-GS-12-571.
    Trial transcript. pp. 2467– 2468

Similar Posts

One Comment

  1. These drugs have definitely made people act in violent ways. Tens to hundreds of thousands of people or more have committed acts of homicide or suicide while suffering under the influence of these drugs. These drugs have also harmed millions of other people by damaging their brains, harming their organs, and causing other terrible effects. There should be a class action lawsuits against the drug manufacturers for contuining to sell a product that they know is harming people and causing some to act in violent ways. It’s not a secret we’ve known about these side effects for years now. It’s time for some accountability for those who have willfully kept harming people with these toxic chemicals.

Leave a Reply

Your email address will not be published. Required fields are marked *